327 related articles for article (PubMed ID: 38058397)
1. Cardiovascular implications of inflammatory bowel disease: An updated review.
Bhardwaj A; Singh A; Midha V; Sood A; Wander GS; Mohan B; Batta A
World J Cardiol; 2023 Nov; 15(11):553-570. PubMed ID: 38058397
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory Bowel Disease and Cardiovascular Diseases.
Chen B; Collen LV; Mowat C; Isaacs KL; Singh S; Kane SV; Farraye FA; Snapper S; Jneid H; Lavie CJ; Krittanawong C
Am J Med; 2022 Dec; 135(12):1453-1460. PubMed ID: 36058305
[TBL] [Abstract][Full Text] [Related]
3. Atherosclerotic cardiovascular disease in inflammatory bowel disease: The role of chronic inflammation.
Weissman S; Sinh P; Mehta TI; Thaker RK; Derman A; Heiberger C; Qureshi N; Amrutiya V; Atoot A; Dave M; Tabibian JH
World J Gastrointest Pathophysiol; 2020 Aug; 11(5):104-113. PubMed ID: 32832194
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory bowel disease and the risk for cardiovascular disease: Does all inflammation lead to heart disease?
Bigeh A; Sanchez A; Maestas C; Gulati M
Trends Cardiovasc Med; 2020 Nov; 30(8):463-469. PubMed ID: 31653485
[TBL] [Abstract][Full Text] [Related]
5. Coronary artery calcium scoring for cardiovascular risk assessment in patients with inflammatory bowel disease.
Naami R; Tashtish N; Neeland IJ; Katz J; Sinh P; Nasir K; Chittajallu V; Mansoor E; Rajagopalan S; Al-Kindi S
Am Heart J; 2023 Dec; 266():120-127. PubMed ID: 37634654
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory Bowel Disease and Atherosclerotic Cardiovascular Disease: JACC Review Topic of the Week.
Cainzos-Achirica M; Glassner K; Zawahir HS; Dey AK; Agrawal T; Quigley EMM; Abraham BP; Acquah I; Yahya T; Mehta NN; Nasir K
J Am Coll Cardiol; 2020 Dec; 76(24):2895-2905. PubMed ID: 33303079
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular Comorbidities and Inflammatory Bowel Disease: Causes and Consequences.
Sinh P; Cross RK
Gastroenterol Hepatol (N Y); 2024 Apr; 20(4):204-215. PubMed ID: 38682122
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD.
Bernstein CN; Benchimol EI; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Kaplan GG
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S73-S80. PubMed ID: 31294387
[TBL] [Abstract][Full Text] [Related]
9. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
10. Thromboembolic and atherosclerotic cardiovascular events in inflammatory bowel disease: epidemiology, pathogenesis and clinical management.
Sleutjes JAM; van Lennep JER; van der Woude CJ; de Vries AC
Therap Adv Gastroenterol; 2021; 14():17562848211032126. PubMed ID: 34377149
[TBL] [Abstract][Full Text] [Related]
11. Impact of biologic therapies and small molecules on the risk of major adverse cardiovascular events in patients with inflammatory bowel diseases: systematic review and meta-analysis of randomized controlled trials.
Shehab M; Alrashed F; Alkazemi A; Lakatos PL; Bessissow T
Expert Rev Gastroenterol Hepatol; 2023 May; 17(5):469-477. PubMed ID: 36961082
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.
Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385
[TBL] [Abstract][Full Text] [Related]
13. Urotensin II levels in patients with inflammatory bowel disease.
Alicic D; Martinovic D; Rusic D; Zivkovic PM; Tadin Hadjina I; Vilovic M; Kumric M; Tokic D; Supe-Domic D; Lupi-Ferandin S; Bozic J
World J Gastroenterol; 2021 Sep; 27(36):6142-6153. PubMed ID: 34629825
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of cardiovascular risk factors in a nationally representative adult population with inflammatory bowel disease without atherosclerotic cardiovascular disease.
Agrawal T; Acquah I; Dey AK; Glassner K; Abraham B; Blankstein R; Virani SS; Blaha MJ; Valero-Elizondo J; Mehta N; Quigley EM; Cainzos-Achirica M; Nasir K
Am J Prev Cardiol; 2021 Jun; 6():100171. PubMed ID: 34327497
[TBL] [Abstract][Full Text] [Related]
15. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular Manifestations in Inflammatory Bowel Disease.
Meda A; Fredrick F; Rathod U; Shah P; Jain R
Curr Cardiol Rev; 2023 Nov; 20(1):. PubMed ID: 38018203
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular Manifestations in Inflammatory Bowel Disease: A Systematic Review of the Pathogenesis and Management of Pericarditis.
Patel RS; Rohit Reddy S; Llukmani A; Hashim A; Haddad DR; Patel DS; Ahmad F; Gordon DK
Cureus; 2021 Mar; 13(3):e14010. PubMed ID: 33884251
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk assessment in inflammatory bowel disease with coronary calcium score.
Chaudhry WAR; Ashfaq M; Kaur P; Kumar M; Faraz M; Malik J; Mehmoodi A
Ann Med Surg (Lond); 2024 Mar; 86(3):1496-1505. PubMed ID: 38463108
[TBL] [Abstract][Full Text] [Related]
19. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
Sinopoulou V; Gordon M; Akobeng AK; Gasparetto M; Sammaan M; Vasiliou J; Dovey TM
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013531. PubMed ID: 34844288
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
